Clinical Pathways promote evidence based, safe, and high-value care for patients by providing clinical recommendations and standard processes. They are developed by multidisciplinary committees of subject matter experts, informed by methodical review of available evidence and consensus among committee members.
The IV Contrast for MRI and CT in Patients with Kidney Disease Synopsis provides a high-level overview of the care standards employed for this Clinical Pathway.
Algorithms associated with this Clinical Pathway:
Inclusion and exclusion criteria:
- Patient between the ages of 1-25 years
- Patient who is considered inpatient, outpatient, or observation
- Patient who is considered emergent or critical (imaging should not be delayed in critical situations)
- Patient less than one year of age
- Patient under hospice care
Committee members involved in the development:
- Darcy Weidemann, MD, MHS| Nephrology | Committee Co-Chair
- Grace Mitchell, MD, MBA | Radiology | Committee Co-Chair
- Joel Thompson, MD | Hematology/Oncology/BMT | Committee Member
- Shobhit Jain, MD | Emergency Medicine | Committee Member
- Adrienne DePorre, MD | Hospital Medicine | Committee Member
- Joel Koenig, MD | Urology | Committee Member
EBP Committee Members:
- Jarrod Dusin, MS, RD, LD, CPHQ | Evidence Based Practice
- Todd Glenski, MD, MSHA, FASA | Anesthesiology, Evidence Based Practice
- Kelli Ott, OTD, OTR/L | Evidence Based Practice
- Finalized date: 12/2022
- Next expected revision date: 12/2025
Concerns with content:
If you have any questions regarding this content or identify a broken link, please email email@example.com.